Joshua Resnick has an estimated net worth of $68.9 Million. This is based on reported shares across multiple companies, which include KalVista Pharmaceuticals, Inc., Vor Biopharma Inc., Aerovate Therapeutics, Inc., AVROBIO, Inc., PepGen Inc., Cidara Therapeutics, Inc., and Sionna Therapeutics, Inc..

2025 was Joshua Resnick's most active year for acquiring shares with 5 total transactions. Joshua Resnick's most active month to acquire stocks was the month of May. 2026 was Joshua Resnick's most active year for disposing of shares, totalling 2 transactions. Joshua Resnick's most active month to dispose stocks was the month of December. 2016 saw Joshua Resnick paying a total of $0.00 for 2,579,490 shares, this is the most they've acquired in one year. In 2026 Joshua Resnick cashed out on 27,279 shares for a total of $0.00, their largest year based on trade value.